Bal Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹87.69 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.47 per cent from ₹74.02 crore. This corresponds to a year-on-year *(YoY) growth of 19.88 per cent.
Operating Profit
Operating Profit stands at ₹9.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 66.67 per cent from ₹5.73 crore. This corresponds to a year-on-year *(YoY) growth of 23.23 per cent.
PBDT
PBDT stands at ₹5.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 67.89 per cent from ₹2.99 crore. This corresponds to a year-on-year *(YoY) growth of 54.46 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 148.61 per cent from ₹0.72 crore. This corresponds to a year-on-year *(YoY) growth of 219.64 per cent.
Net Profit
Net Profit stands at ₹1.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 148.61 per cent from ₹0.72 crore. This represents a 244.23 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bal Pharma Ltd Earnings
- YOY
- QOQ
Bal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bal Pharma Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bal Pharma Ltd Financial Reports
Bal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bal Pharma | 2.77% | 5.69% | -3.88% | -1.19% | -15.91% | -7.16% |
| Achyut Healthcar | 7.98% | 6.73% | -6.72% | -0.89% | 5.11% | 70.77% |
| Lactose (India) | 0.26% | -2.74% | -0.35% | -17.58% | -25.09% | -7.14% |
| Pharmaids Pharma | -5.00% | -0.59% | -12.09% | -32.40% | -42.39% | -51.67% |
| Krebs Biochem | -3.65% | 3.81% | -8.70% | -24.14% | -29.20% | -27.52% |
| Tyche Industries | 0.95% | 2.02% | -4.56% | -6.72% | -20.39% | -15.03% |
| Novelix Pharma. | -2.06% | 6.70% | -10.06% | -7.25% | 41.02% | 112.93% |
Company Info
Company Information
ED / MD / Promoter : Shailesh Siroya
E D & Wholetime Director : Himesh Virupakshaya
Independent Non Exe. Director : H S Venkatesh
Independent Non Exe. Director : Nicola Neeladri
Independent Non Exe. Director : Jatish Sheth
Independent Non Exe. Director : Ravindrakumar Kothari
Company Sec. & Compli. Officer : Abdul Basith
Additional Director : Bheekamchand Mukesh